Advertisement
Australia markets open in 9 hours 55 minutes
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • AUD/USD

    0.6490
    -0.0010 (-0.16%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.33
    -0.48 (-0.58%)
     
  • Bitcoin AUD

    97,656.47
    -4,226.67 (-4.15%)
     
  • CMC Crypto 200

    1,370.75
    -11.82 (-0.85%)
     

Is AbbVie a Buy?

Is AbbVie a Buy?

Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. AbbVie last reported its earnings in July. Humira remains key to AbbVie's business for now, generating $5.4 billion this past quarter, nearly three times the $1.8 billion Skyrizi and Rinvoq generated.